Welcome to the e-CCO Library!

P108: has been withdrawn
Year: 2021
Source: ECCO'21 Virtual
Created: Wednesday, 2 June 2021, 4:12 PM
P108: Identifying Patient-Centered Future Research Priorities: A Report from the Patient Reported Outcomes after Pouch Surgery (PROPS) Delphi Consensus Study
Year: 2022
Source: ECCO'22
Authors: Cavallaro, P.(1);Bordeianou, L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P108: Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Larussa T.*1, Oliverio M.1, Suraci E.1, Greco M.1, Placida R.1, Gervasi S.1, Marasco R.1, Imeneo M.1, Paolino D.1, Tucci L.2, Gulletta E.1, Fresta M.1, Procopio A.1, Luzza F.1

Created: Wednesday, 20 February 2019, 10:36 AM
P108: Validation of a new score for paediatric Crohn's disease on a paediatric tertiary hospital: the MINI-Index (Mucosal Inflammation Non-Invasive Index)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. González Pérez1, G. Pujol Muncunill*1, V. Vila Miravet1, J. Martin de Carpi1

Created: Friday, 22 February 2019, 9:41 AM
P109 Construction of a suite of computable biological network models focused on inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P.A. Ruiz Castro, H. Yepiskoposyan, J. Szostak, M. Talikka, J. Hoeng

Created: Thursday, 30 January 2020, 10:12 AM
P109: Analysis of the clinical, gastroscopic, and pathological features of upper gastrointestinal lesions in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Li1, Q. Yang1, Z. Huang1, J. Zhao1, K. Cao1, J. Tang1, X. Fan2, H. Chen3, Y. Huang2, C. Li3, M. Zhi1, P. Hu1, X. Gao*1

Created: Friday, 22 February 2019, 9:41 AM
P109: Effect of dysbiosis on the growth and colitis susceptibility in DSS colitis model
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. S. Eun*, D. S. Han, A. R. Lee, Y. R. Lee

Created: Friday, 22 February 2019, 9:49 AM
P109: Impact of ethnicity on colorectal cancer incidence in a cohort of colitis-associated dysplasia patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Kabir, M.(1,2);Curtius, K.(3,4);Kalia, P.(5);Al Bakir, I.(1,2);Choi, C.H.R.(6);Hartono, J.L.(7,8);East, J.E.(9,10);Lindsay, J.O.(11,12);Vega, R.(13);Thomas-Gibson, S.(1,2);Graham, T.A.(3);Hart, A.(1,2);Wilson, A.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P109: Profiling of receptor for advanced glycation end products expression in cases of primary sclerosing cholangitis with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Udupa V.1, Baird A.2, Winter D.*3

Created: Wednesday, 20 February 2019, 10:36 AM
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Konturek1*, Y. Zopf2, W. Dieterich2, S. Wirtz3, M.F. Neurath2, T. Brzozowski4

Created: Thursday, 21 February 2019, 9:14 AM
P109: Risk of cervical cancer in incident Ulcerative Colitis during the first 10 years after diagnosis: A nationwide population-based study
Year: 2022
Source: ECCO'22
Authors: Kim, J.(1);Kim, H.(2);Park, S.C.(2);Lee, J.K.(3);Kang, D.R.(3);Kim, S.Y.(2);Kim, H.S.(2);Kim, H.M.(2);
Created: Friday, 11 February 2022, 3:52 PM
P109: Using baseline Peripheral blood mononuclear cell (PBMC) transcriptomics of Crohn Disease patients receiving Ustekinumab treatment as a tool to assess potential response at 1 year
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Granot, M.(1); Braun, T.(2); Efroni, G.(2); Fudim, E.(2);Yavzori, M.(2);Haj, O.(3); Ben-Horin, S.(3);Kopylov, U.(3);Haberman Ziv, Y.(1)*;
Created: Friday, 14 July 2023, 10:48 AM
P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Huhn1, M. Herrero San Juan1, B. Melcher2, C. Dreis1, K. Schmidt1, J.M. Pfeilschifter1, M. Vieth2, J. Stein3, H.H. Radeke1

Created: Thursday, 30 January 2020, 10:12 AM
P110: Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bernardo D.*1, Mora-Gutierrez I.1, Marin A.c.1, Díaz-Guerra A.1, Caminero-Fernández R.2, Caldas M.2, De la Morena F.2, Jiménez M.2, Chaparro M.1, Gisbert J.P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P110: Cigarette smoke modulates the effect of dextran sulfate sodium–induced colitis on a subpopulation of T-cells in blood and colon in mice
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Daniluk*1, U. Daniluk2, M. Rusak3, J. Reszec4, M. Dabrowska3, A. Dabrowski1

Created: Friday, 22 February 2019, 9:49 AM
P110: Fibroblast activation protein is strongly expressed in intestinal fibrosis in inflammatory bowel disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lartey, D.(1,2)*;van Roest, M.(1);Verhoeff, J.(1,3);Grootjans, J.(1,2);Buskens, C.(4);van der Bilt, J.(4,5);Wildenberg, M.(1);D'Haens, G.(2);Löwenberg, M.(2);
Created: Friday, 14 July 2023, 10:48 AM
P110: Inter-rater validity of a new scoring index for Crohn’s disease (Crohn's disease activity in capsule endoscopy)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Omori*1, K. Yasuhiro1, S. Murasugi1, H. Kambayashi1, T. Hara1, A. Ito1, M. Yonezawa1, S. Nakamura1, K. Tokushige1

Created: Friday, 22 February 2019, 9:41 AM
P110: Risk Factors of Clinical Relapses in Pediatric Luminal Crohn’s Disease, a Retrospective Cohort Study
Year: 2022
Source: ECCO'22
Authors: Sassine, S.(1,2);Djani, L.(1,2);Cambron-Asselin, C.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Qaddouri, M.(1,2);Fadela-Zekhnine, S.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P110: Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey
Year: 2021
Source: ECCO'21 Virtual
Authors: Dotson, J.(1);Hunter, T.(2);Lukanova, R.(3);Crandall, W.(4);Komocsar, W.(4);Larkin, A.(4);Meakin, S.(3);Otley, A.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P110: TIGIT expression identifies circulating CD38+ effector T cells with immune regulatory properties whose frequencies at diagnosis predict disease course of paediatric IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Joosse1*, C. Menckeberg1, L.F. de Ruiter1, H. Raatgeep1, L.A. van Berkel1, Y. Simons-Oosterhuis1, M. Joosse2, R.W. Hendriks2, R.M. Hoogenboezem3, T. Cupedo3, L. de Ridder4, J. Escher4, S. Veenbergen1, J.N. Samsom1

Created: Thursday, 21 February 2019, 9:14 AM